1. Adjuvant durvalumab post-chemoradiotherapy in stage III non-small cell lung cancer: experience from the Edinburgh Cancer Centre. (March 2022) Authors: Yan, Xiangfei; Price, Gareth; Raynes, George; Stares, Mark; Evans, Tamasin; Campbell, Sorcha; Tufail, Aisha; MacLennan, Kirsty; Barrie, Colin; MacKean, Melanie; Harrow, Stephen; Phillips, Iain Journal: Lung cancer Issue: Volume 165(2022)Supplement 1 Page Start: S34 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Audit of cyclophosphamide/adriamycin/vincristine (CAV) chemotherapy use in Edinburgh Cancer Centre. (June 2021) Authors: Boh, Zhuang; Little, Felicity; MacKean, Melanie; Barrie, Colin; Campbell, Sorcha; Evans, Tamasin Journal: Lung cancer Issue: Volume 156(2021)Supplement 1 Page Start: S65 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Biomarkers of systemic inflammation predict survival in stage III non-small cell lung cancer treated with chemoradiotherapy. (March 2022) Authors: Langley, Benjamin; Leach, James; Fenner, Florence; Killean, Angus; Barrie, Colin; Maclennan, Kirsty; Campbell, Sorcha; Evans, Tamasin; Tufail, Aisha; Harrow, Stephen; McMenemy, Maria; MacKean, Melanie; Phillips, Iain; Stares, Mark Journal: Lung cancer Issue: Volume 165(2022)Supplement 1 Page Start: S53 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Comparing local and trial outcomes in patients receiving chemoradiation for non-small cell lung cancer (NSCLC). (October 2019) Authors: Budden Horne, Ashley William; Evans, Tamasin; Phillips, Iain Journal: Clinical oncology Issue: Volume 31(2019)Supplement 1 Page Start: e12 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Gross tumour volume predicts survival and correlates with pre-treatment serum albumin concentration in patients with stage III non-small cell lung cancer treated with chemo-radiotherapy. (March 2022) Authors: Killean, Angus; Fenner, Florence; Stares, Mark; Evans, Tamasin; Maclennan, Kirsty; Tufail, Aisha; Campbell, Sorcha; Harrow, Stephen; McLaren, Duncan; Phillips, Iain Journal: Lung cancer Issue: Volume 165(2022)Supplement 1 Page Start: S56 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Pre-treatment serum albumin is a prognostic biomarker for locally advanced non-small cell lung cancer: extended follow up of patients treated with concurrent chemo-radiotherapy. (June 2021) Authors: Killean, Angus; Horne, Ashley; Phillips, Iain; Maclennan, Kirsty; Evans, Tamasin; Little, Felicity; Tufail, Aisha; Stares, Mark Journal: Lung cancer Issue: Volume 156(2021)Supplement 1 Page Start: S3 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Quality of life after breast-conserving therapy and adjuvant radiotherapy for non-low-risk ductal carcinoma in situ (BIG 3-07/TROG 07.01): 2-year results of a randomised, controlled, phase 3 trial. Issue 5 (May 2020) Authors: King, Madeleine T; Link, Emma K; Whelan, Tim J; Olivotto, Ivo A; Kunkler, Ian; Westenberg, Antonia Helen; Gruber, Guenther; Schofield, Penny; Chua, Boon H; Chua, Boon H; Phillips, Claire; Bryant, Guy; Westenberg, Helen; Purohit, Om Pra-Kesh; Ahern, Verity; Graham, Peter; Akra, Mohamed; McArdle, O... Journal: Lancet oncology Issue: Volume 21:Issue 5(2020) Page Start: 685 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Real world prospective data on tyrosine kinase inhibitors in the treatment of epidermal growth factor receptor mutation positive non-small cell lung cancer at the Edinburgh Cancer Centre. (June 2021) Authors: Swan, Amanda; Boh, Zhuang; Patrizio, Ailsa; Phillips, Iain; Evans, Tamasin; MacLennan, Kirsty; Tufail, Aisha; Barrie, Colin; MacKean, Melanie Journal: Lung cancer Issue: Volume 156(2021)Supplement 1 Page Start: S32 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Real-world outcomes for patients with inoperable stage III non-small cell lung cancer: a prognostic role for albumin?. (March 2022) Authors: Leach, James; Stares, Mark; Langley, Benjamin; Fenner, Florence; Killean, Angus; Barrie, Colin; Maclennan, Kirsty; Campbell, Sorcha; Evans, Tamasin; Tufail, Aisha; Harrow, Stephen; McMenemy, Maria; Mackean, Melanie; Phillips, Iain Journal: Lung cancer Issue: Volume 165(2022)Supplement 1 Page Start: S58 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Scottish Immunotherapy Prognostic Score: biomarker of systemic inflammation predicts response to first-line pembrolizumab for metastatic non-small cell lung cancer. (June 2021) Authors: Ding, Tze-en Grace; Thomson, Findlay; Stratton, Cory; Cumming, Kirsten; Barrie, Colin; Maclennan, Kirsty; Evans, Tamasin; Campbell, Sorcha; Tufail, Aisha; Mackean, Melanie; Phillips, Iain; Stares, Mark Journal: Lung cancer Issue: Volume 156(2021)Supplement 1 Page Start: S43 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗